EYS-606

N/A

Report date: 2024/09/19 15:13:38

Base Information

Drug NameEYS-606
Drug Alias NameEYS-606
ClassificationCell and gene therapy > Gene therapy > Plasmid
Mechanisms of ActionTumor necrosis factor α inhibitorsGene transference
TargetsTumor necrosis factor α
Therapy Area/IndicationsUveitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited KingdomFrance
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesEyevensys SAS
China Registration ClassN/A

Develop Information

Active CompaniesEyevensys SAS
Inactive CompaniesN/A
Active IndicationsUveitis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A